Tozzo P, Caenazzo L
Department of Molecular Medicine. University of Padua, Padova, Italy - Department of Biotechnologies and Sciences of Life. Insubria University, Varese, Italy.
Department of Molecular Medicine. University of Padua, Padova, Italy.
Clin Ter. 2015;166(4):170-5. doi: 10.7417/CT.2015.1865.
Gender differences, in both clinical and research environment, exist also in a particular category of patients, adolescents, who constitute a vulnerable group with respect to healthcare decisions. In clinical context, the main ethical issues that may be identified within gender medicine for adolescent patients are related to the information given to the patient and its parents, the adolescent's capacity of understanding considering his/her maturity, vulnerability and autonomy, the consent to medical treatment in relation to the different possible approaches to their different efficacy and possible side effects. Also, with regard to the research context, ethical issues may arise from the participation of female minors in clinical trials. Ethical concerns may also arise in the field of resource allocation in health policies, such as the equitable distribution and access to resources, considering the young age of the subjects involved. A bioethical reflection, which takes into account not only the differences biologically and epidemiologically relevant, but also the main determinants of health in adolescence, might find a role in structured education for diversity and gender equity. Given the magnitude of the problem, to encourage the pursuit of gender equity in health and, in some situations, also to promote the full recognition of the right to health of women are some of the most effective and direct ways to reduce inequalities and to ensure a rational and efficient use of available resources, including through a bioethical reflection on the topic. The Authors show the necessity to differentiate the various aspects of gender differences in adolescence medicine, providing arguments in support of the fact that interventions for health prevention and promotion should be modulated in relation to the gender of the recipients, emphasizing the most important aspects for each group of individuals. This approach could implement personalized medicine, even and especially considering gender differences, benefiting from the contribution that a bioethical reflection can provide.
在临床和研究环境中,性别差异在一类特殊患者——青少年中也存在,青少年在医疗决策方面是弱势群体。在临床环境中,青少年患者性别医学中可能识别出的主要伦理问题与向患者及其父母提供的信息、青少年考虑其成熟度、脆弱性和自主性的理解能力、针对不同疗效和可能副作用的不同治疗方法的医疗同意有关。此外,在研究环境中,女性未成年人参与临床试验可能引发伦理问题。在卫生政策的资源分配领域也可能出现伦理问题,例如考虑到相关主体的年轻年龄,资源的公平分配和获取。一种生物伦理反思,不仅考虑生物学和流行病学上相关的差异,还考虑青少年健康的主要决定因素,可能在多样性和性别平等的结构化教育中发挥作用。鉴于问题的严重性,鼓励在卫生领域追求性别平等,在某些情况下,促进充分承认妇女的健康权,是减少不平等和确保合理有效利用现有资源的一些最有效和直接的方式,包括通过对该主题进行生物伦理反思。作者表明有必要区分青春期医学中性别差异的各个方面,提供论据支持这样一个事实,即健康预防和促进干预措施应根据接受者的性别进行调整,强调每组个体最重要的方面。这种方法可以实施个性化医疗,特别是考虑到性别差异,受益于生物伦理反思所能提供的贡献。